Richard M. Jelinek's most recent trade in Evolent Health Inc - Ordinary Shares - Class A was a trade of 21,979 Class A Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Inc - Ordin... | Richard M. Jelinek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 21,979 | 36,437 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | Richard M. Jelinek | Director | Purchase of securities on an exchange or from another person at price $ 9.16 per share. | 07 Mar 2025 | 15,000 | 15,000 (0%) | 0% | 9.2 | 137,400 | Class A Common Stock |
| Evolent Health Inc - Ordin... | Richard M. Jelinek | Director | Purchase of securities on an exchange or from another person at price $ 9.09 per share. | 07 Mar 2025 | 15,000 | 15,000 (0%) | 0% | 9.1 | 136,350 | Class A Common Stock |
| Evolent Health Inc - Ordin... | Richard M. Jelinek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,709 | 14,458 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | Richard M. Jelinek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,049 | 6,749 (0%) | 0% | 0 | Class A Common Stock |